Home > Income Statement > ORCHID PHARMA

ORCHID PHARMA
Revenue

    Back to Income Statement
ORCHID PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹922 Cr₹819 Cr₹666 Cr₹560 Cr₹450 Cr

What is the latest Revenue of ORCHID PHARMA ?

The latest Revenue ratio of ORCHID PHARMA is ₹922 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹922 Cr
Mar2024₹819 Cr
Mar2023₹666 Cr
Mar2022₹560 Cr
Mar2021₹450 Cr

How is Revenue of ORCHID PHARMA Trending?

Years Revenue % Change
Mar2025 ₹922 Cr
12.52
Mar2024 ₹819 Cr
23.05
Mar2023 ₹666 Cr
19.00
Mar2022 ₹560 Cr
24.33
Mar2021 ₹450 Cr -

Compare Revenue of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹5,280.7 Cr 3.4% 0.7% 49.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹463,815.0 Cr 0.5% 6.2% 17.3% Stock Analytics
DIVIS LABORATORIES ₹192,678.0 Cr 4.7% 9% 7% Stock Analytics
TORRENT PHARMACEUTICALS ₹161,323.0 Cr -3.7% 7.2% 49.8% Stock Analytics
CIPLA ₹114,585.0 Cr -0.6% 5% -3.2% Stock Analytics
DR REDDYS LABORATORIES ₹101,067.0 Cr -1.9% -4.6% -2.8% Stock Analytics


ORCHID PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

3.4%

0.7%

49.7%

SENSEX

0.8%

1.8%

-6.5%


You may also like the below Video Courses